INS and Insulin resistance: In principle, positive effects through an increased ALA consumption by itself on cardiovascular and diabetic risk factors are described in the literature, with a range of doses (approx. 1.2–8 g/d ALA) achieving significant effects on, e.g., blood pressure, total cholesterol, LDL cholesterol, triglycerides, insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) with a study duration of 12 weeks [71,72,73].